Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancers
Martin Gutierrez, Robin Guo, Giuseppe Giaccone, Stephen V. Liu, Zhonglin Hao, Christie Hilton, James M. Hinson, Mark G. Kris, Everardus Orlemans, Alexander Drilon
Topics & Concepts
MedicineCarboplatinPaclitaxelNauseaAdverse effectInternal medicineLung cancerOncologyCancerSurgeryChemotherapyCisplatinHeat shock proteins researchLung Cancer Treatments and MutationsEffects of Radiation Exposure